Big Pharma layoff rounds jump 281% in '24
CVS Health launches CostVantage model
Orbis raises $93M to turn popular biologics into pills
Novo asks FDA to restrict Victoza compounding amid GLP-1 outsourcing row
*please scroll down for all the latest news*